Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-465 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10 |
filingDate |
2003-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2006503046-A |
titleOfInvention |
Oral formulation with modified release |
abstract |
The present invention relates to a glassy matrix oral solid preparation useful for transmucosal oral administration of an active agent such as nicotine. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603516-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603517-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011519862-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8343532-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015232012-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016020385-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010523587-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007504207-A |
priorityDate |
2002-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |